Star Health Insurance and Allied Insurance Company Limited has announced an analyst/institutional investor meeting scheduled for February 04, 2026 in Mumbai. The company informed both BSE and NSE about this regulatory disclosure under Regulation 30 through a formal communication dated February 03, 2026.

Meeting Details

The investor meeting is scheduled with specific timing and participant details as outlined by the company.

Regulatory Compliance

The company has fulfilled its disclosure obligations by notifying both major stock exchanges. Star Health trades on BSE with scrip code 543412 and on NSE under the symbol STARHEALTH. The communication was signed by Jayashree Sethuraman, Company Secretary & Compliance Officer, ensuring proper corporate governance protocols.

Short Notice Acknowledgment

Due to business exigencies on the part of the investors, the company scheduled this meeting at shorter notice than usual. Star Health has expressed regret for the abbreviated timeline and committed to ensuring timely intimation of future analyst and institutional investor meetings. This demonstrates the company's commitment to maintaining transparent communication practices with stakeholders.

Presentation Access

The company has provided access to meeting materials through a dedicated presentation link. Additionally, the disclosure will be made available on the company's official website at www.starhealth.in , ensuring broader accessibility for interested stakeholders and maintaining transparency standards required under regulatory guidelines.

ICICI Prudential Mutual Fund has announced a significant reduction in its shareholding in star health insurance through a substantial share sale disclosed under SEBI regulations. The mutual fund sold 1,22,29,062 shares of the insurance company during an extended period from May 2025 to January 2026.

Major Shareholding Reduction

The fund's shareholding in Star Health and Allied Insurance Company Ltd has decreased substantially following the share sale transaction. The reduction represents a decline of more than 2% of the company's paid-up capital compared to the previous disclosure made on May 05, 2025.

Transaction Details and Regulatory Compliance

The disclosure was made in compliance with Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The shares were sold through secondary market transactions over an extended period spanning approximately nine months.

Key Transaction Highlights:

• Net sale of 15,07,850 shares executed on January 29, 2026
• Total disposal of 1,22,29,062 shares since the last filing on May 05, 2025
• All transactions conducted through secondary market sales
• No encumbrances, voting rights, or convertible securities involved

Company Capital Structure Changes

Star Health and Allied Insurance Company's equity share capital showed marginal changes during the transaction period. The company's paid-up capital increased slightly from the last filing date, affecting the percentage calculations for the shareholding disclosure.

Investment Perspective Declaration

ICICI Prudential Mutual Fund emphasized that its holding in Star Health and Allied Insurance Company is maintained from an investment perspective rather than seeking any controlling interest in the company. This clarification aligns with typical mutual fund investment strategies focused on portfolio diversification and returns rather than corporate control.

The disclosure was signed by Rakesh Shetty, Chief Compliance Officer & Company Secretary of ICICI Prudential Asset Management Company Limited, and submitted to BSE Limited on January 30, 2026. The fund continues to hold 1,83,14,995 shares representing 3.11% stake in the insurance company after the substantial disposal.